Impact Biomedical (IBO) Change in Cash (2022 - 2026)
Impact Biomedical's (IBO) quarterly Change in Cash came in at $17000.0 in Q1 2026, up 102.5% YoY from $8395.2 in Q1 2025, and up 288.89% on a QoQ basis from -$9000.0 in Q4 2025.
Impact Biomedical (IBO) Change in Cash (2022 - 2026) Analysis & Trends
Impact Biomedical (IBO) has 5 years of Change in Cash data on file, last reported at $17000.0 in Q1 2026.
- Quarterly Change in Cash rose 102.5% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 198.63% YoY) and the FY2025 annual result came in at -$2.0 million, down 199.9% from the prior year.
- Change in Cash rose to $17000.0 in Q1 2026, from -$9000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.7 million in Q3 2024 to a low of -$694000.0 in Q2 2025.
- A 5-year average of -$7928.6 and a median of -$19500.0 in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash soared 1246.46% — and 2025, when it tumbled 68200.0%.
- Tracing IBO's Change in Cash over 5 years: stood at -$99000.0 in 2022, then tumbled by 102.02% to -$200000.0 in 2023, then tumbled by 234.5% to -$669000.0 in 2024, then surged by 98.65% to -$9000.0 in 2025, then jumped by 288.89% to $17000.0 in 2026.
- The last three Change in Cash figures came in at $17000.0 (Q1 2026), -$9000.0 (Q4 2025), and -$612000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -612,000.00 |
| Jun 30, 2025 | -694,000.00 |
| Mar 31, 2025 | -681,000.00 |
| Dec 31, 2024 | -669,000.00 |
| Sep 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | 198,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -99,000.00 |
| Sep 30, 2022 | -30,000.00 |